tyrosine and Chronic Hepatitis C

tyrosine has been researched along with Chronic Hepatitis C in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (20.00)18.2507
2000's3 (30.00)29.6817
2010's5 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aizawa, N; Enomoto, H; Hasegawa, K; Iijima, H; Ikeda, N; Ishii, A; Ishii, N; Iwata, Y; Miyamoto, Y; Nakano, C; Nishiguchi, S; Nishikawa, H; Nishimura, T; Sakai, Y; Takashima, T; Takata, R; Yoh, K; Yuri, Y1
Inoue, J; Iwata, T; Kakazu, E; Kogure, T; Morosawa, T; Nakamura, T; Ninomiya, M; Sano, A; Shimosegawa, T; Takai, S; Umetsu, T1
Brigandi, R; Chuang, WL; Gardner, S; Goodman, Z; Husa, P; Jonas, M; Levine, R; Makhlouf, H; McHutchison, J; Patel, K; Rockey, D; Rodriguez-Torres, M; Schultz, M; Shiffman, M; Stancil, B; Theodore, D; Watson, H; Webster, A1
Krupińska, J; Pobłocki, J; Syrenicz, A; Urbanowicz, W; Wawrzynowicz-Syczewska, M1
Bezemer, G; de Knegt, RJ; Fekkes, D; Hansen, BE; Janssen, HL; Van Gool, AR; Vrolijk, JM1
Caputi, AP; Cuzzocrea, S; Longo, G; Villari, D; Zingarelli, B1
Hayashi, Y; Kasuga, M; Kumon, Y; Nagano, H; Ninomiya, T; Seo, Y; Shimizu, K; Sugano, M; Yoon, S1
Apolinario, A; García-Monzón, C; Majano, PL; Moreno-Otero, R; Sanz, P; Zubia, I1
De Bie, S; De Paepe, A; De Vos, M; Delanghe, JR; Leroux-Roels, G; Messiaen, L; Praet, M; Van Vlierberghe, H1
Hayashi, H; Ikeda, R; Imaizumi, Y; Kawanaka, M; Sanae, F; Shiono, Y; Takikawa, T; Wakusawa, S; Yamada, G; Yano, M; Yoshioka, K1

Trials

1 trial(s) available for tyrosine and Chronic Hepatitis C

ArticleYear
Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection.
    Gastroenterology, 2010, Volume: 138, Issue:4

    Topics: Adult; Aged; Biopsy; Double-Blind Method; Female; Hepatitis C, Chronic; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Oxazoles; PPAR gamma; Tyrosine

2010

Other Studies

9 other study(ies) available for tyrosine and Chronic Hepatitis C

ArticleYear
Predictors Associated with Increase in Skeletal Muscle Mass after Sustained Virological Response in Chronic Hepatitis C Treated with Direct Acting Antivirals.
    Nutrients, 2017, Oct-18, Volume: 9, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Amino Acids, Branched-Chain; Antiviral Agents; Biomarkers; Body Composition; Electric Impedance; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Hyaluronic Acid; Logistic Models; Male; Middle Aged; Multivariate Analysis; Muscle, Skeletal; Retrospective Studies; Sustained Virologic Response; Time Factors; Treatment Outcome; Tyrosine; Viral Load

2017
The profiling of plasma free amino acids and the relationship between serum albumin and plasma-branched chain amino acids in chronic liver disease: a single-center retrospective study.
    Journal of gastroenterology, 2018, Volume: 53, Issue:8

    Topics: Adult; Aged; Amino Acids, Branched-Chain; Chronic Disease; Disease Progression; Female; Hepatitis C, Chronic; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Male; Middle Aged; Non-alcoholic Fatty Liver Disease; Retrospective Studies; Serum Albumin; Severity of Illness Index; Tyrosine

2018
The influence of interferon alpha on the induction of autoimmune thyroiditis in patients treated for chronic viral hepatitis type C.
    Endokrynologia Polska, 2011, Volume: 62, Issue:6

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Autoimmunity; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Thyroglobulin; Thyroid Gland; Thyroiditis, Autoimmune; Thyrotropin; Time Factors; Triiodothyronine; Tyrosine; Young Adult

2011
Psychiatric side effects and fluctuations in serotonergic parameters in the treatment of chronic hepatitis C infection.
    Neuropsychobiology, 2012, Volume: 65, Issue:3

    Topics: Adult; Antiviral Agents; Chromatography, High Pressure Liquid; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Mood Disorders; Neopterin; Phenylalanine; Polyethylene Glycols; Prolactin; Psychometrics; Recombinant Proteins; Serotonin; Statistics, Nonparametric; Time Factors; Tyrosine

2012
Evidence for in vivo peroxynitrite production in human chronic hepatitis.
    Life sciences, 1998, Volume: 63, Issue:2

    Topics: Adult; Antibodies; Antibody Specificity; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunohistochemistry; Liver Cirrhosis; Male; Middle Aged; Nitrates; Tyrosine

1998
Improvement of molar ratio of branched-chain amino acids to tyrosine (BTR) associated with liver fibrosis in chronic hepatitis C patients treated with interferon-alpha.
    Digestive diseases and sciences, 1999, Volume: 44, Issue:5

    Topics: Adult; Aged; Amino Acids, Branched-Chain; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Liver Cirrhosis; Male; Middle Aged; Tyrosine

1999
Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease.
    Journal of hepatology, 2000, Volume: 32, Issue:2

    Topics: Adult; Female; Hepatitis; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunologic Techniques; Liver; Male; Middle Aged; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Severity of Illness Index; Tissue Distribution; Tyrosine

2000
Association between Cys282Tyr missense mutation and haptoglobin phenotype polymorphism in patients with chronic hepatitis C.
    European journal of gastroenterology & hepatology, 2001, Volume: 13, Issue:9

    Topics: Adult; Aged; Alleles; Case-Control Studies; Chi-Square Distribution; Cohort Studies; Cysteine; Female; Genetic Predisposition to Disease; Genetic Testing; Haptoglobins; Hepatitis C, Chronic; Humans; Male; Middle Aged; Mutation, Missense; Phenotype; Polymorphism, Genetic; Prevalence; Probability; Reference Values; Risk Assessment; Tyrosine

2001
C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan.
    Internal medicine (Tokyo, Japan), 2001, Volume: 40, Issue:9

    Topics: Adult; Asian People; Aspartic Acid; Cysteine; Female; Hemochromatosis; Hemochromatosis Protein; Hepatitis C, Chronic; Histidine; Histocompatibility Antigens Class I; HLA Antigens; Humans; Iron Overload; Japan; Liver Diseases; Male; Membrane Proteins; Middle Aged; Point Mutation; Polymerase Chain Reaction; Tyrosine

2001